Regulatory Announcement
Publication of Final Terms
Bank of Montreal has agreed to issue AUD 84,000,000 6.455 per cent. Senior Notes due June 2034, Series 271 (the "Notes") pursuant to its U.S.$20,000,000,000 Note issuance Programme (the "Programme").
The following document constitutes the final terms dated June 23, 2022 (the "Final Terms") relating to the admission to trading of the Notes for purpose of Article 8 of Regulation (EU) 2017/1129 and as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (EUWA) and must be read in conjunction with the Prospectus dated July 16, 2021, as supplemented by the 1st Supplement dated August 25, 2021, the 2nd Supplement dated December 10, 2021, the 3rd Supplement dated January 4, 2022, the 4th Supplement dated January 10, 2022, the 5th Supplement dated March 1, 2022, the 6th Supplement dated March 14, 2022 and the 7th Supplement dated May 25, 2022 (together, the "Prospectus"). Full information on Bank of Montreal and the offer of the Notes is only available on the basis of the combination of the Final Terms and the Prospectus.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms you must ascertain from the Prospectus, as supplemented by these Final Terms, whether or not you are part of the intended addressees of the information contained therein.
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and are subject to US tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in the United States or to or for the account of US persons (as defined in Regulation S under the Securities Act). No public offering of the Notes is being made in the United States.
Your right to access this service is conditional upon complying with the above requirement.
UK MiFIR professionals / ECPs-only / No PRIIPs KID - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA and the UK.
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/0342Q_1-2022-6-23.pdf
For further information, please contact:
Sara Virani
Corporate Secretary's Dept.
Phone: 647-207-1635
Email: sara.virani@bmo.com
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
